CME Group Inc. (NASDAQ:CME) Holdings Decreased by Beese Fulmer Investment Management Inc.

Beese Fulmer Investment Management Inc. cut its holdings in shares of CME Group Inc. (NASDAQ:CME) by 3.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,240 shares of the financial services provider’s stock after selling 50 shares during the quarter. Beese Fulmer Investment Management Inc.’s holdings in CME Group were worth $274,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Salomon & Ludwin LLC acquired a new stake in CME Group during the first quarter valued at $28,000. Y.D. More Investments Ltd acquired a new stake in shares of CME Group during the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. grew its stake in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares in the last quarter. Asset Dedication LLC increased its holdings in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its position in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CME. Oppenheimer increased their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday. JPMorgan Chase & Co. upped their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Piper Sandler lifted their price objective on CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 8th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a research note on Tuesday, October 8th. Finally, Morgan Stanley lifted their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $222.07.

CME Group Stock Performance

NASDAQ CME opened at $229.69 on Friday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market cap of $82.70 billion, a P/E ratio of 26.13, a PEG ratio of 7.76 and a beta of 0.55. The company’s 50-day simple moving average is $218.08 and its 200 day simple moving average is $208.66.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company posted $2.25 EPS. As a group, research analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.00%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.